Clinical Trial

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Study acronym: ELSDI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-04-13; most recent amendment 2025-05-26.
Trial Details
NCT Number NCT05338294
Lead Sponsor Northern Jiangsu People's Hospital
Conditions Cirrhosis, Liver, Splenectomy; Status
Enrollment 20 participants
Start Date 2022-03-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-28